* iRhythm Technologies Inc reported a quarterly adjusted loss of $1.26 per share for the quarter ended January 1, lower than the same quarter last year, when the company reported EPS of -89 cents. The mean expectation of twelve analysts for the quarter was for a loss of 57 cents per share. Wall Street expected results to range from -67 cents to -46 cents per share.
* Revenue rose 18.4% to $147.54 million from a year ago; analysts expected $146.73 million.
* iRhythm Technologies Inc's reported EPS for the quarter was a loss of $1.48.
* The company reported a quarterly loss of $46.18 million.
* iRhythm Technologies Inc shares had risen by 3.7% this quarter and lost 28.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 3% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for iRhythm Technologies Inc is $115.00 This summary was machine generated from LSEG data October 31 at 02:42 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 -0.57 -1.26 Missed
Jun. 30 2024 -0.89 -0.61 Beat
Mar. 31 2024 -0.96 -1.23 Missed
Dec. 31 2023 -0.59 -1.26 Missed
Comments